Effect of mesenchymal stem cells on cardiac function and restenosis of injuried artery after myocardial infarction

National Medical Journal of China

Volumn 91, Issue 32, 2011, Pages 2269-2273

  Shi, Bei ^a   Liu, Zhi Jiang ^a   Zhao, Ran Zun ^a   Long, Xian Ping ^a   Wang, Dong Mei ^a   Wang, Zheng Long ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Endothelium, Vascular; Myocardial infarction; Restenosis; Stem cells

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CD31 ANTIGEN; CYCLINE;

ANGIOGRAPHY; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAPILLARY DENSITY; CAROTID ARTERY; CELL HOMING; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; NEOINTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTEIN EXPRESSION; RESTENOSIS; ANIMAL; DISEASE MODEL; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT; VASCULAR ENDOTHELIUM;

ANIMALS; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; RABBITS;

EID: 84870422644     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.32.011     Document Type: Article

References (18)

1. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature, 2001, 410: 701-705.
2. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol, 2004, 94: 92-95.
3. Vulliet PR, Greeley M, Halloran SM, et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet, 2004, 363: 783-784.
4. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet, 2004, 363: 751-756.
5. 2009, 40: 923-926.
6. 2009, 37: 441-443.
7. Strauer BE, Brehm M, Zeus T, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr, 2001, 126: 932-938.
8. 2009, 89: 1067-1070.
9. Tang J, Wang J, Yang J, et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg, 2009, 36: 644-650.
10. Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol, 2009, 54: 2277-2286.
11. 2010, 90: 317-321.
12. Wu X, Huang L, Zhou Q, et al. Mesenchymal stem cells participating in ex vivo endothelium repair and its effect on vascular smooth muscle cells growth. Int J Cardiol, 2005, 105: 274-282.
13. Iwase T, Nagaya N, Fujii T, et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res, 2005, 66: 543-551.
14. Silva GV, Litovsky S, Assad JA, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 2005, 111: 150-156.
15. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med, 2005, 11: 367-368.
16. 2010, 90: 496-498.
17. Takahashi M, Suzuki E, Oba S, et al. Adipose tissue-derived stem cells inhibit neointimal formation in a paracrine fashion in rat femoral artery. Am J Physiol Heart Circ Physiol, 2008, 298: H415-423.
18. Johansson U, Rasmusson I, Niclou SP, et al. Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes, 2008, 57: 2393-2401.